Clinical Trials

Gastrointestinal Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 3 of 3 Clinical Trials Related to Gastrointestinal Cancer

EA2174 GI Junction

A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

...
Doctor(s) Running This Study
Maged F. Khalil, MD

MSK 19-377 Gastric Cancer

A Phase 2, Open-Label, Single-Arm Trial of Trastuzumab Deruxtecan (DS-8201A) in HER2-Positive, Unresectable or Metastatic Gastric or Gastro-Esophageal Junction (GEJ) Adenocarcinoma Subjects Who Have Progressed on or After a Trastuzumab

...
Doctor(s) Running This Study
Maged F. Khalil, MD

S1922

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

...
Doctor(s) Running This Study
Maged F. Khalil, MD